Standout Papers

Lebrikizumab Treatment in Adults with Asthma 2011 2026 2016 2021 1.1k
  1. Lebrikizumab Treatment in Adults with Asthma (2011)
    Jonathan Corren, Robert F. Lemanske et al. New England Journal of Medicine
  2. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials (2016)
    Nicola A. Hanania, Phillip E. Korenblat et al. The Lancet Respiratory Medicine

Immediate Impact

23 from Science/Nature 127 standout
Sub-graph 1 of 16

Citing Papers

Fibrosis: from mechanisms to medicines
2020 StandoutNature
Feeding-dependent VIP neuron–ILC3 circuit regulates the intestinal barrier
2020 StandoutNature
29 intermediate papers

Works of Phillip E. Korenblat being referenced

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
2015
Lebrikizumab Treatment in Adults with Asthma
2011 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Phillip E. Korenblat 1971 1292 652 943 41 2.7k
B Assoufi 2541 1339 887 1177 25 3.2k
G Barnéon 1920 1072 645 690 89 2.8k
J.V. Collins 2285 1808 591 797 51 3.5k
Qutayba Hamid 1677 850 525 985 19 2.4k
Sophie Molet 1600 807 574 1549 25 3.1k
John G. Matthews 3263 2008 1045 1379 41 4.2k
David Gossage 1677 1265 445 555 27 2.4k
Eleanor Minshall 1313 684 583 556 28 2.0k
Sabrina Mattoli 2425 1785 747 1280 69 4.5k
Pota Christodoulopoulos 1300 554 735 706 29 2.0k

All Works

Loading papers...

Rankless by CCL
2026